Lantheus Holdings IncLNTH
Price$99.65Intrinsic value$101.302% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $101.30median of 6 methods · middle span $74-$240based on filings through 30 Jun 2026
Market Price $99.65Price as of 1 Oct 2026
Margin of Safety +1.7%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.5% (near-term consensus, capped) · years 2–5: 8.7%/yr (balance of the path).8.1% per year
Years 6–10: glide to demonstrated growth own history 23.2%, capped at 20%
Per-year rates
Yr 68.6%Yr 78.4%Yr 88.3%Yr 98.2%Yr 108.1%
8.7% → 8.1%
Years 11–20: glide to long-run rate
Per-year rates
Yr 117.5%Yr 127.0%Yr 136.5%Yr 146.0%Yr 155.5%Yr 165.0%Yr 174.5%Yr 184.0%Yr 193.5%Yr 203.0%
8.1% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 2 windows (6/7y) (limited history)23.2%
Discount rate (cost of equity) 6.3%
Volatility vs market (adjusted beta)0.31

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetLantheus Holdings IncLNTHHealth Care
Valuation
P/E23.8×
P/S4.2×
P/B4.9×
EV / Revenue4.2×
EV / EBITDA14.7×
Profitability
Gross margin61.2%
Operating margin21.6%
Net margin17.7%
FCF margin24.7%
Returns
ROE21.0%
ROA11.4%
ROIC21.4%
Growth
Revenue growth (YoY)1.5%
5-yr fwd EPS growth8.1%
Financial strength
Debt / Equity0.43×
Current ratio3.06×
Altman Z-Score5.5
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.